Contact Us

Pulmonary Drugs Market Poised to Grow at a CAGR of 4.3% by 2025


Infinium Global Research has added a new report on the Pulmonary Drugs Market. The report presents an analysis of global as well as regional markets of pulmonary drugs market over the period of 2017 to 2025. Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global pulmonary drugs market but also make strategic decisions to capture the most lucrative markets in the near future. The market size is presented in terms of value for the historic year 2017 and estimated for the forecast period of 2019-2025.

 

Get a 15% discount for early purchase of global pulmonary drugs market report by clicking the following link, Use code IGRD15 to request the discount in the given form

 

https://www.infiniumglobalresearch.com/reports/request-discount/5918

 

The recent report identified that North America dominated the global pulmonary drugs market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the pulmonary drugs market worldwide.

 

The report segments the global pulmonary drugs market on the basis of drug class, application, and distribution channel.

 

Global Pulmonary Drugs Market by Drug Class

·         Long-acting Beta2-agonists (LABA)

·         Short-acting Beta2-agonists (SABA)

·         Anticholinergics

·         Inhaled Corticosteroids (ICS)

·         Antihistamines

·         Vasodilators

·         Other Drug Class

 

Global Pulmonary Drugs Market by Application

·         Pulmonary Arterial Hypertension

·         Cystic Fibrosis

·         Asthma & COPD

·         Other Applications

 

Global Pulmonary Drugs Market by Distribution Channel

·         Hospital Pharmacies

·         Retail Pharmacies

·         Drug Stores

·         Other Distribution Channel

 

Companies Profiled in the Report

·         Sunovion Pharmaceuticals Inc.

·         AstraZeneca

·         Novartis AG

·         Bayer AG

·         F. Hoffmann-La Roche Ltd

·         GlaxoSmithKline Plc.

·         Teva Pharmaceutical Industries Ltd.

·         Merck Sharp & Dohme Corp

·         Boehringer Ingelheim International GmbH.

·         Actelion Pharmaceuticals Ltd

·         Others

 

About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which is blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.




sign up for our newsletter